Robert A. Freitas Jr. (2009 Foresight Institute Feynman Prize in Nanotechnology for Theory) has made available on his website “Comprehensive Nanorobotic Control of Human Morbidity and Aging” [1.8 MB PDF], Chapter 23 in Gregory M. Fahy, Michael D. West, L. Stephen Coles, and Steven B. Harris, eds, The Future of Aging: Pathways to Human Life Extension, Springer, New York, 2010, pp. 685-805. Freitas writes:

…a current update and the most comprehensive summary so far of the many potential applications of advanced diamondoid medical nanorobotics to conventional and anti-aging medicine. Here’s the abstract:

Nanotechnology involves the engineering of molecularly precise structures and molecular machines, and nanomedicine is the application of nanotechnology to medicine, including the development of medical nanorobotics. Theoretical designs for diamondoid nanomachinery such as bearings, gears, motors, pumps, sensors, manipulators and even molecular computers already exist. Technologies required for the molecularly precise fabrication of diamondoid mechanical components and medical nanorobots, along with feasible strategies for the mass production of these devices, are the focus of active current research. This chapter describes a comprehensive solution to human morbidity and aging which will be attained when mankind has established control over all critical molecular events in the human body through the use of medical nanorobotics. Medical nanorobots can provide targeted treatments to individual organs, tissues, cells and even intracellular components, and can intervene in biological processes at the molecular level under direct supervision of the physician. Programmable micron-scale robotic devices will make possible comprehensive cures for human disease, the reversal of physical trauma, and individual cell repair. This leads to the complete control of human aging via nanomedically engineered negligible senescence (NENS) coupled with nanorobot-mediated rejuvenation that should extend the human healthspan at least tenfold beyond its current maximum length. The nanomedical solution is the final step in the roadmap to the control of human aging.

Best wishes,

Robert A. Freitas Jr.
Author, Nanomedicine and
Senior Research Fellow, Institute for Molecular Manufacturing